SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS)

Historical Holders from Q4 2019 to Q3 2025

Symbol
SLS on Nasdaq
CUSIP
81642T209
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
106M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
32.9M
Holdings value
$53M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
92
Number of buys
49
Number of sells
-25
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 6.7% $9.44M 6.69M The Vanguard Group Jun 30, 2025
Anson Funds Management LP 5.7% +16% $9.71M $1.3M 6.03M +15.4% Anson Funds Management LP Sep 30, 2025
BlackRock, Inc. 5.4% $9.16M 5.69M BlackRock, Inc. Sep 30, 2025

Institutional Holders of SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 32.9M $53M +$9.8M $1.61 92
2025 Q2 26.8M $58.6M +$27.5M $2.19 78
2025 Q1 14.3M $15.4M +$8.74M $1.08 43
2024 Q4 6.2M $6.44M +$751K $1.04 29
2024 Q3 5.39M $6.73M +$1.66M $1.25 33
2024 Q2 4.06M $4.83M -$3.47M $1.19 33
2024 Q1 7.72M $7.79M +$4.3M $1.01 29
2023 Q4 3.41M $3.61M +$286K $1.06 27
2023 Q3 2.75M $4.51M -$594K $1.64 26
2023 Q2 3.09M $4.86M +$176K $1.57 21
2023 Q1 2.98M $4.26M +$1.44M $1.43 21
2022 Q4 1.89M $4.46M +$93.3K $2.36 28
2022 Q3 2.18M $4.41M -$489K $2.02 23
2022 Q2 2.98M $6.64M +$1.67M $2.23 23
2022 Q1 1.66M $11.1M -$277K $6.68 21
2021 Q4 1.73M $9.55M -$1.35M $5.53 24
2021 Q3 1.86M $17.1M -$844K $9.16 29
2021 Q2 1.9M $21.3M +$3.09M $11.10 28
2021 Q1 1.55M $13.2M +$5.29M $8.54 27
2020 Q4 925K $5.37M +$2.5M $5.81 19
2020 Q3 617K $1.63M +$397K $2.65 10
2020 Q2 456K $1.34M +$145K $2.93 12
2020 Q1 416K $720K -$87.8K $1.74 10
2019 Q4 389K $1.67M +$1.67M $4.30 9